Interleukin-6 Inhibition and Cardiovascular Disease in Patients With Rheumatoid Arthritis

Terapevticheskii Arkhiv - Russian Federation
doi 10.17116/terarkh201688593-101
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Media Sphere Publishing Group

Related search

The Importance of Interleukin 6 Inhibition in Juvenil Rheumatoid Arthritis

The Bulletin of Contemporary Clinical Medicine
2020English

Rheumatoid Arthritis and Cardiovascular Disease

Current Opinion in Rheumatology
Rheumatology
2013English

Blockade of Interleukin 6 Signaling Induces Marked Neutropenia in Patients With Rheumatoid Arthritis

Journal of Rheumatology
RheumatologyAllergyImmunology
2009English

Aspirin Use in Rheumatoid Arthritis Patients With Increased Risk of Cardiovascular Disease

ISRN Rheumatology
2013English

Different Rating of Global Rheumatoid Arthritis Disease Activity in Rheumatoid Arthritis Patients With Multiple Morbidities

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2017English

B-Lymphocyte Subpopulations in Patients With Rheumatoid Arthritis and the Effect of an Interleukin-6 Receptor Inhibitor on Them.

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2019English

The Protective Effect of IL-6 Blockade on Glucose and Cardiovascular Risk in Patients With Active Rheumatoid Arthritis

Revista de Chimie
SurfacesMaterials ScienceEngineeringMaterials ChemistryFilmsCoatingsChemistry
2001English

Association of Interleukin 6 Receptor Variant With Cardiovascular Disease Effects of Interleukin 6 Receptor Blocking Therapy

JAMA Cardiology
Cardiovascular MedicineCardiology
2018English

Autoimmunity and Inflammation Link to Cardiovascular Disease Risk in Rheumatoid Arthritis

Rheumatology and Therapy
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy